A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib
一项前瞻性、多中心、全面的基因组特征研究，针对一线奥希替尼治疗失败的EGFR突变晚期非小细胞肺癌患者。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02481-8
Shi, Yuankai; Lv, Dongqing; Feng, Weineng; Liu, Shuoyan; Xing, Puyuan; Yu, Yan; Yin, Jun; Ren, Xiubao; Zhang, Junqiang; Han, Gaohua; Zhang, Yongchang; Cang, Shundong; Chen, Jun; Chen, Enguo; Meng, Lingxin; Zhang, Yong
